Is Mounjaro available on the NHS for weight loss?

Who actually qualifies for Mounjaro on the NHS at the moment?

NICE approved tirzepatide for NHS use in England in December 2024 (Technology Appraisal TA1026), but the rollout is structured in cohorts so that commissioners and GP practices can absorb demand gradually. The thresholds are deliberately tight at each stage.

The first cohort (active since June 2025) covers adults with a BMI of 40 or above plus four or more of five specific conditions: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, and type 2 diabetes. That is a high bar. Cohort 2 activated on 23 June 2026, lowering the BMI threshold to 35–39.9 while keeping the requirement for four or more of those same conditions. The next planned expansion, scheduled around March 2027, moves to BMI 40 or above with three qualifying conditions.

Throughout all phases, BMI thresholds are reduced by 2.5 kg/m² for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds. And every NHS patient must participate in wrap-around diet and activity support, Mounjaro alone is not issued without it. You can read the precise recommendations in NICE's appraisal of tirzepatide (TA1026).

If you want to understand the full trajectory of the rollout before deciding your next step, our page on when Mounjaro will be available on the NHS sets out each cohort's expected timeline in plain terms.

Does Mounjaro now available on the NHS mean your GP can prescribe it?

From 1 April 2026, GP practices in England gained the ability to prescribe tirzepatide under the new GP contract (QOF 2026/27). So yes, in theory, a standard GP appointment could end with a Mounjaro prescription. In practice, participation is optional at practice level, and many surgeries are not yet set up for it, either because they have not joined the scheme, they do not have the wrap-around support infrastructure, or their local Integrated Care Board has additional criteria.

Scotland, Wales and Northern Ireland operate separate commissioning arrangements. Access criteria differ there and are generally still more restricted than England's phased rollout. The picture in Wales specifically is covered in more detail on a dedicated page.

The honest answer, then, is that Mounjaro is now technically available on the NHS across much of England for those who meet the criteria, but whether your particular GP practice can and will prescribe it is a separate question worth asking directly. Qualifying for Mounjaro through the NHS is not simply a matter of ticking a BMI box.

What is the alternative if you do not meet NHS criteria or cannot wait?

Private treatment through a regulated online pharmacy is the route most people outside the NHS thresholds are taking. There is no referral letter, no waiting list and no requirement to have multiple qualifying conditions. If you are unsure whether tirzepatide is available on the NHS for someone in your situation, that page walks through the eligibility picture clearly. The clinical standard is the same: tirzepatide is a prescription-only medicine and a qualified prescriber must assess you before anything is dispensed. The difference is speed and access, not the safety process.

At nume, every consultation is reviewed the same day by a GPhC-registered Independent Prescriber, a real clinician reading your answers, not automated software making a decision. Once approved and you order by 12pm on a working day, your treatment is dispatched that afternoon and arrives the next working day via DPD in plain, unbranded packaging, tracked to your door.

Cost is a real consideration. The private market price for tirzepatide has risen since Eli Lilly revised its UK list price in September 2025, for context on what that means for private pricing, our page on the Eli Lilly Mounjaro price increase in the UK explains the background. If you want to understand what private treatment includes before starting, you can also read about how buying Mounjaro online works through a regulated service.

Private treatment is not the right choice for everyone. But for people who sit just below NHS thresholds, or who have been waiting months without progress, it is a clinically legitimate path. The prescriber's assessment at consultation determines whether it is appropriate for you specifically. If you'd like to know more about what sets nume apart, our about page covers how the service is built. When you are ready to take the next step, you can start your free consultation with no commitment required.